Point-of-Care Diagnostics Market, 2019-2023: Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers--Supplier Shares, Test Volume and Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
Market Segmentation Analysis
- Review of the emerging POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
- Five-year test volume and reagent sales forecasts for chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment:
- Cancer Clinics
- Ambulatory Care Centers
- Surgery Centers
- Nursing Homes
- Birth Centers
and by test category:
- Routine and Special Chemistry
- Microbiology/Infectious Diseases
- Hematology
- Flow Cytometry
- Coagulation
- Immunoproteins
- Drugs of Abuse
- TDM
- Endocrine Function
- Tumor Markers
Sales and Market Share Analysis
- Sales and market shares of major reagent and instrument suppliers.
Current and Emerging Products
- Analysis of over 130 diagnostic procedures.
- Review of the leading POC chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.
Technology Review
- Emerging technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.
Competitive Assessments
- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.
Strategic Recommendations
- Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.
Methodology
This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and the proprietary data files.
Introduction
Executive Summary
Rationale for Testing Decentralization
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
Worldwide Market and Technology Overview
1. AIDS
2. Adenovirus
3. Campylobacter
4. Candida
5. Chlamydia
6. Clostridium Difficile
7. Cytomegalovirus
8. Enteroviruses
9. Epstein-Barr Virus
10. Gonorrhea
11. Helicobacter Pylori
12. Hepatitis
a. Hepatitis A
b. Hepatitis B
c. Hepatitis C
d. Hepatitis D
13. Herpes Simplex Virus
14. Human Herpes Virus-6 (HHV-6)
15. Influenza Viruses
16. Legionella
17. Lyme Disease
18. Measles (Rubeola)
19. Meningitis
20. Mononucleosis
21. Mumps
22. Mycoplasma
23. Papillomaviruses
24. Pneumonia
25. Respiratory Syncytial Virus (RSV)
26. Rheumatoid Arthritis
27. Rotavirus (Reovirus)
28. Rubella (German Measles)
29. Salmonellosis
30. Shigellosis
31. Staphylococcus Aureus
32. Streptococci
33. Syphilis
Instrumentation: Infectious Disease Analyzers Manufactured by:
- Abbott
- Beckman Coulter/Danaher
- bioMeriuex
- Ortho-Clinical Diagnostics
- Roche
- Siemens
- Tosoh
- Wallac, and other suppliers
Current and Emerging Technologies
1. Monoclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
? Overview
? ELISA
? Dot Immunobinding Assays
? Capillary Immunoassays
? Particle-Membrane Capture Immunoassay
? Enzyme Amplification
c. Fluorescent Immunoassays
? Fluorescent Polarization
? Time-Resolved Pulse Fluorescence
d. Luminescence
? Chemiluminescence
? Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
3. Dry Chemistry
4. Biosensors
5. IT and Automation
6. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
? Polymerase Chain Reaction
? Ligase Chain Reaction
? Branched DNA
? Q-Beta Replicase
? Strand Displacement Activation
? Self-Sustained Sequence Replicase
U.S.A.
A. Market Overview
1. Business Environment
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
? PPO
? HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
? More Chronic Illness
? Disease Incidence
? Susceptibility to latrogenesis
? Multiple Illnesses Cases
l. Laboratory Regulations
2. Market Structure
a. Hospitals
b. Commercial/Private Laboratories
C. Physician Offices/Group Practices
1. Market Summary
2. Market Structure
3. Test Volume and Sales Forecasts
D. Ancillary Hospital Locations
1. Introduction
a. Emergency Departments
b. Operating Suites
c. Intensive Care Units
2. Emergency Departments
a. Market Summary
b. Test volume and Sales Forecasts
3. Operating and Recovery Suites
a. Market Summary
b. Test Volume and Sales Forecasts
4. ICUs/CCUs
a. Market Summary
b. Test Volume and Sales Forecasts
E. Cancer Clinics
1. Introduction
2. Market Summary
3. Test Volume and Sales Forecasts
F. Ambulatory Care Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
G. Surgery Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
H. Nursing Homes
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
I. Birth Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
J. Major Suppliers Instrument Placements,
Installed Base, Reagent Sales and Market Shares
Major Product Development Opportunities
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Company Profile
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako
List Of Tables
Major Companies Developing or Marketing
AIDS Tests
Major Companies Developing or Marketing
Adenovirus Tests
Major Companies Developing or Marketing
Campylobacter Tests
Major Companies Developing or Marketing
Candida Tests
Major Companies Developing or Marketing
CMV Tests
Major Companies Developing or Marketing
EBV Tests
Major Companies Developing or Marketing
Gonorrhea Tests
Major Companies Developing or Marketing
Helicobacter Pylori Tests
Major Companies Developing or Marketing
Hepatitis Tests
Major Companies Developing or Marketing
Herpes Tests
Major Companies Developing or Marketing
Influenza Tests
Major Companies Developing or Marketing
Legionella Tests
Major Companies Developing or Marketing
Lyme Disease Tests
Major Companies Developing or Marketing
Measles Tests
Major Companies Developing or Marketing
Meningitis Tests
Major Companies Developing or Marketing
Mononucleosis Tests
Major Companies Developing or Marketing
Mumps Tests
Major Companies Developing or Marketing
Mycoplasma Tests
Major Companies Developing or Marketing
Pneumonia Tests
Major Companies Developing or Marketing
RSV Tests
Major Companies Developing or Marketing
Rotavirus Tests
Major Companies Developing or Marketing
Rubella Tests
Major Companies Developing or Marketing
Salmonella Tests
Major Companies Developing or Marketing
Shigella Tests
Major Companies Developing or Marketing
Streptococci Tests
Major Companies Developing or Marketing
Syphilis Tests
U.S.A., Physician Office/Group Practice
Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices
Forecast by Type
U.S.A., Office-Based Physicians
Forecast by Practice Type
U.S.A., Physician Offices/Group Practices
Infectious Disease Test Volume Forecast
U.S.A., Physician Offices/Group Practices
Microbiology Test Volume Forecast
U.S.A., Physician Offices/Group Practices
Infectious Disease Reagent and Instrument Sales Forecast
U.S.A., Physician Offices/Group Practices
Microbiology Reagent and Instrument Sales Forecast
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments
Infectious Disease Test Volume Forecast
U.S.A., Hospital Emergency Departments
Infectious Disease Reagent
and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Estimated
Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers
Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers
Infectious Disease Test Volume Forecast
U.S.A., Ambulatory Care Centers Microbiology
And Serology Test Volume Forecast
U.S.A., Ambulatory Care Centers
Infectious Disease Reagent and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Microbiology
and Serology Reagent and Instrument Sales Forecast
U.S.A., Surgery Centers Most
Frequently Performed Procedures
U.S.A., Surgery Centers Microbiology
and Serology Test Volume Forecast
U.S.A., Surgery Centers Microbiology
And Serology Reagent and Instrument Sales Forecast
U.S.A., Birth Centers Facilities,
Patient Visits, and Births
U.S.A., Birth Centers Microbiology
and Serology Test Volume Forecast
U.S.A., AIDS Testing Market
Estimated Market Shares of Major Suppliers
U.S.A., Chlamydia Testing Market
Estimated Market Shares of Major Suppliers
U.S.A., CMV Testing Market
Estimated Market Shares of Major Suppliers
U.S.A., Gonorrhea Testing Market
Estimated Market Shares of Major Suppliers
U.S.A., Helicobacter Pylori Testing Market
Estimated Market Shares of Major Suppliers
U.S.A., Hepatitis Testing Market
Estimated Market Shares of Major Suppliers
U.S.A., Herpes Testing Market
Estimated Market Shares of Major Suppliers
U.S.A., Influenza Testing Market
Estimated Market Shares of Major Suppliers
U.S.A., Lyme Disease Testing Market
Estimated Market Shares of Major Suppliers
U.S.A., Mononucleosis Testing Market
Estimated Market Shares of Major Suppliers
U.S.A., Rubella Testing Market
Estimated Market Shares of Major Suppliers
U.S.A., Streptococci Testing Market
Estimated Market Shares of Major Suppliers
U.S.A., Syphilis Testing Market
Estimated Market Shares of Major Suppliers
Point-of-Care Diagnostics Devices And Equipment Global Market Report 2020 Including: 1) By Type: Infectious disease testing kits, Cardio metabolic monitoring kits,, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Others 2) By End User: Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home Covering: Abbott, F. Hoffmann-La Roche, Siemens Healthineers, Danaher, Beckman Coulter
Point-of-Care Diagnostics Devices And Equipment Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global
View ReportVeterinary Diagnostic Equipment Global Market Report 2020 Including: 1) By Product: Hematology, Immunodiagnostics, Clinical Chemistry, Molecular Testing 2) By End Users: Hospitals & Clinics, Reference Laboratories, Universities/Research Centers, Point-of-Care/In-House Testing 3) By Animal: Livestock Cattle, Domestic Pets Covering: IDEXX Laboratories, ABAXIS, HESKA Corporation, Zoetis, Virbac
Veterinary Diagnostic Equipment Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global veterinary diagnostic
View ReportPoint-of-Care Diagnostics Devices And Equipment Global Market Report 2020 Including: 1) By Type: Infectious disease testing kits, Cardio metabolic monitoring kits,, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Others 2) By End User: Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home Covering: Abbott, F. Hoffmann-La Roche, Siemens Healthineers, Danaher, Beckman Coulter
Point-of-Care Diagnostics Devices And Equipment Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global
View ReportGlobal Immunodiagnostics Market, 2019-2023: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, 2019-2023--Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, Special Chemistry, Therapeutic Drug Monitoring (TDM), Tumor Markers
This new report is a strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations.
View ReportFill The Form For Sample Request